These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 7505854)

  • 1. [HIV drug resistance and its genetic basis].
    Tsuchie H; Sakamoto T; Kurimura T
    Nihon Rinsho; 1993 Sep; 51 Suppl():610-4. PubMed ID: 7505854
    [No Abstract]   [Full Text] [Related]  

  • 2. [Reverse transcriptase inhibitors as anti-HIV agents].
    Shirasaka T; Mitsuya H
    Nihon Rinsho; 1993 Sep; 51 Suppl():192-9. PubMed ID: 7505846
    [No Abstract]   [Full Text] [Related]  

  • 3. Convergent combination therapy can select viable multidrug-resistant HIV-1 in vitro.
    Larder BA; Kellam P; Kemp SD
    Nature; 1993 Sep; 365(6445):451-3. PubMed ID: 7692302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of evolutionary limitations of HIV-1 multidrug resistance to optimize therapy.
    Chow YK; Hirsch MS; Merrill DP; Bechtel LJ; Eron JJ; Kaplan JC; D'Aquila RT
    Nature; 1993 Feb; 361(6413):650-4. PubMed ID: 7679778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic evolution of HIV-1 isolates from patients after a switch of therapy from zidovudine to didanosine.
    Masquelier B; Pellegrin I; Ruffault A; Ragnaud JM; Morlat P; Michelet C; Doignon F; Biteau N; Fleury HJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Apr; 8(4):330-4. PubMed ID: 7533640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of genotypic resistance to nucleoside analogues in antiretroviral-naive and antiretroviral-experienced HIV-infected patients in Spain.
    Gómez-Cano M; Rubio A; Puig T; Pérez-Olmeda M; Ruiz L; Soriano V; Pineda JA; Zamora L; Xaus N; Clotet B; Leal M
    AIDS; 1998 Jun; 12(9):1015-20. PubMed ID: 9662197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV and multidrug resistance.
    Emini EA; Graham DJ; Gotlib L; Condra JH; Byrnes VW; Schleif WA
    Nature; 1993 Aug; 364(6439):679. PubMed ID: 7689173
    [No Abstract]   [Full Text] [Related]  

  • 8. Didanosine resistance in HIV-infected patients switched from zidovudine to didanosine monotherapy.
    Kozal MJ; Kroodsma K; Winters MA; Shafer RW; Efron B; Katzenstein DA; Merigan TC
    Ann Intern Med; 1994 Aug; 121(4):263-8. PubMed ID: 7518658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.
    Shafer RW; Winters MA; Jellinger RM; Merigan TC
    J Infect Dis; 1996 Aug; 174(2):448-9. PubMed ID: 8699089
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of selective polymerase chain reaction primers and differential probe hybridization of polymerase chain reaction products for determination of relative amounts of codon 215 mutant and wild-type HIV-1 populations.
    Eastman PS; Urdea M; Besemer D; Stempien M; Kolberg J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):264-73. PubMed ID: 7540490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highlights of the Fourth International Workshop on HIV Drug Resistance.
    Lange JM; deJong MD
    J Int Assoc Physicians AIDS Care; 1995 Aug; 1(7):25-7. PubMed ID: 11362748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure.
    Rusconi S; De Pasquale MP; Milazzo L; Kurtagic S; Bulgheroni E; Citterio P; Galazzi M; La Seta Catamancio S; Galli M
    Antivir Ther; 1998; 3(4):203-7. PubMed ID: 10682139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations conferring resistance to zidovudine diminish the antiviral effect of stavudine plus didanosine.
    Izopet J; Bicart-See A; Pasquier C; Sandres K; Bonnet E; Marchou B; Puel J; Massip P
    J Med Virol; 1999 Dec; 59(4):507-11. PubMed ID: 10534734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Didanosine (Videx).
    Res Initiat Treat Action; 2000 Mar; 6(1):8-9. PubMed ID: 11708189
    [No Abstract]   [Full Text] [Related]  

  • 15. Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
    Richman DD
    J Enzyme Inhib; 1992; 6(1):55-64. PubMed ID: 1285303
    [No Abstract]   [Full Text] [Related]  

  • 16. Zidovudine-resistant human immunodeficiency virus selected by passage in cell culture.
    Larder BA; Coates KE; Kemp SD
    J Virol; 1991 Oct; 65(10):5232-6. PubMed ID: 1716689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZT-related mutation Lys70Arg in reverse transcriptase of human immunodeficiency virus type 1 confers decrease in susceptibility to ddATP in in vitro RT inhibition assay.
    Sharma PL; Chatis PA; Dogon AL; Mayers DL; McCutchan FE; Page C; Crumpacker CS
    Virology; 1996 Sep; 223(2):365-9. PubMed ID: 8806572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT).
    Dis Markers; 1990; 8(3):163-4. PubMed ID: 1703061
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infrequent deletion in 67 codon in HIV reverse transcriptase in antiretroviral treatment failure].
    Giri J; Jáuregui Rueda H; Monticelli A; Pirola DA; Planes N
    Medicina (B Aires); 2001; 61(2):193-5. PubMed ID: 11374145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug resistance. An updated, user-friendly guide to genotype interpretation.
    MacArthur RD
    AIDS Read; 2000 Nov; 10(11):652-7. PubMed ID: 11186189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.